Another step forward in the progressive rebuilding
30/10/24 -"Clariane’s turnover growth continued to be driven by increases in both volume and pricing across all the business segments and regions. The group also advanced its €1bn disposal program for ..."
Pages
51
Language
English
Published on
30/10/24
You may also be interested by these reports :
06/02/26
Coloplast delivered a weak Q1, with both revenue and adjusted EBIT missing consensus. Organic growth of 6% was in line with expectations, but ...
06/02/26
Qiagen’s Q4 results surpassed both market expectations and management’s guidance, with most segments reporting gains. The 2026 guidance aligns with ...
05/02/26
GN’s Q4 results fell short of market expectations. While Hearing experienced healthy growth, this was overshadowed by weaknesses in Gaming and ...
05/02/26
Our estimates have been moderated following the Q4 25 miss, primarily reflecting a softer order book and growth momentum (especially for the LS ...